Order Article Reprints

Steele TM, Talbott GC, Sam A, Tepper CG, Ghosh PM, Vinall RL. Obatoclax, a BH3 Mimetic, Enhances Cisplatin-Induced Apoptosis and Decreases the Clonogenicity of Muscle Invasive Bladder Cancer Cells via Mechanisms That Involve the Inhibition of Pro-Survival Molecules as Well as Cell Cycle Regulators. International Journal of Molecular Sciences. 2019; 20(6):1285. https://doi.org/10.3390/ijms20061285

Steele, Thomas M., George C. Talbott, Anhao Sam, Clifford G. Tepper, Paramita M. Ghosh, and Ruth L. Vinall. 2019. "Obatoclax, a BH3 Mimetic, Enhances Cisplatin-Induced Apoptosis and Decreases the Clonogenicity of Muscle Invasive Bladder Cancer Cells via Mechanisms That Involve the Inhibition of Pro-Survival Molecules as Well as Cell Cycle Regulators" International Journal of Molecular Sciences 20, no. 6: 1285. https://doi.org/10.3390/ijms20061285

Steele, T. M., Talbott, G. C., Sam, A., Tepper, C. G., Ghosh, P. M., & Vinall, R. L. (2019). Obatoclax, a BH3 Mimetic, Enhances Cisplatin-Induced Apoptosis and Decreases the Clonogenicity of Muscle Invasive Bladder Cancer Cells via Mechanisms That Involve the Inhibition of Pro-Survival Molecules as Well as Cell Cycle Regulators. International Journal of Molecular Sciences, 20(6), 1285. https://doi.org/10.3390/ijms20061285